| Supplementary Protection Certificate (SPC) Summary | |||||||||||||||||
| SPC No. | 2007/011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Date of filing | 27/02/2007 | ||||||||||||||||
| Notification of Application Published | 21/03/2007 | ||||||||||||||||
| Status | Expired | ||||||||||||||||
| Notification of Grant Published | 19/06/2013 | ||||||||||||||||
| Date of Expiry of SPC | 02/03/2019 | ||||||||||||||||
| Applicant |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES The National Institute of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 Rockville, MD 20852 UNITED STATES OF AMERICA |
||||||||||||||||
| Patent Number | 0662132 | ||||||||||||||||
| Title of Invention | SELF-ASSEMBLING RECOMBINANT HPV16 PAPILLOMAVIRUS CAPSID PROTEINS | ||||||||||||||||
| Date of Expiry of Patent | 02/09/2013 | ||||||||||||||||
| Product Type | Medicinal Product | ||||||||||||||||
| Product Identity | Human Papillomavirus Type 16 L1 Protein | ||||||||||||||||
| Market Authorisation | Ireland | ||||||||||||||||
| Authorisation No | EU/1/06/357/001-017 & EU/1/06/358/001-017 | ||||||||||||||||
| Authorisation Date | 20/09/2006 | ||||||||||||||||
| Identity of Product Authorised | |||||||||||||||||
| Address for Service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||||||||||||||||
| Renewal Fees |
|
||||||||||||||||
| 02/09/2016 | Application for an extension of the duration of Supplementary Protection Certificate No. 2007/011 filed on 19/08/2016. | ||||||||||||||||
| 14/12/2016 | Application for an extension of the duration of Supplementary Protection Certificate No. 2007/011 granted on 14/12/2016. New expiry date of Supplementary Protection Certificate, as extended, is 02/03/2019. | ||||||||||||||||
| 05/07/2018 | The year 26 renewal fee for SPC number 2007/011 was paid on the 25/06/2018. | ||||||||||||||||
| 27/03/2019 | SPC expired on 02/03/2019. | ||||||||||||||||
